Rage (Receptor for Advanced Glycation End Products) in Melanoma Progression
The Receptor for Advanced Glycation End Products (RAGE) and its ligands are expressed in multiple cancer types and are implicated in cancer progression. Our lab has previously reported higher transcript levels of RAGE and S100B in advanced staged melanoma patients. The contribution of RAGE in the pa...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
North Dakota State University
2018
|
| Online Access: | https://hdl.handle.net/10365/27415 |